JP2004526756A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526756A5
JP2004526756A5 JP2002580090A JP2002580090A JP2004526756A5 JP 2004526756 A5 JP2004526756 A5 JP 2004526756A5 JP 2002580090 A JP2002580090 A JP 2002580090A JP 2002580090 A JP2002580090 A JP 2002580090A JP 2004526756 A5 JP2004526756 A5 JP 2004526756A5
Authority
JP
Japan
Prior art keywords
quinoline
methoxy
carboxylic acid
phenylamino
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002580090A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526756A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/010657 external-priority patent/WO2002081728A2/en
Publication of JP2004526756A publication Critical patent/JP2004526756A/ja
Publication of JP2004526756A5 publication Critical patent/JP2004526756A5/ja
Pending legal-status Critical Current

Links

JP2002580090A 2001-04-06 2002-04-04 hYAK1及びhYAK3キナーゼのキノリン阻害剤 Pending JP2004526756A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28222901P 2001-04-06 2001-04-06
PCT/US2002/010657 WO2002081728A2 (en) 2001-04-06 2002-04-04 Quinoline inhibitors of hyak1 and hyak3 kinases

Publications (2)

Publication Number Publication Date
JP2004526756A JP2004526756A (ja) 2004-09-02
JP2004526756A5 true JP2004526756A5 (US06780888-20040824-C00057.png) 2006-01-05

Family

ID=23080586

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002580090A Pending JP2004526756A (ja) 2001-04-06 2002-04-04 hYAK1及びhYAK3キナーゼのキノリン阻害剤

Country Status (5)

Country Link
US (1) US7087758B2 (US06780888-20040824-C00057.png)
EP (1) EP1372654A4 (US06780888-20040824-C00057.png)
JP (1) JP2004526756A (US06780888-20040824-C00057.png)
AU (1) AU2002256085A1 (US06780888-20040824-C00057.png)
WO (1) WO2002081728A2 (US06780888-20040824-C00057.png)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100453946B1 (ko) * 2002-10-11 2004-10-20 (주) 비엔씨바이오팜 6-메틸피리딘 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
WO2004034985A2 (en) * 2002-10-16 2004-04-29 Smithkline Beecham Corporation Chemical compounds
WO2005070042A2 (en) * 2004-01-09 2005-08-04 Smithkline Beecham Corporation Novel chemical compounds
AR053602A1 (es) * 2005-05-03 2007-05-09 Smithkline Beecham Corp Compuesto de 2- arilamino -4-oxo-1,3-tiazol-5(4h)- substituido, composicion farmaceutica que lo comprende, proceso para prepararla y uso del compuesto para preparar un medicamento
PE20070083A1 (es) * 2005-06-08 2007-01-27 Smithkline Beecham Corp (5z)-5-(6-quinoxalinilmetilideno)-2-[(2,6-diclorofenil)amino]-1,3-tiazol-4(5h)-ona
US7547782B2 (en) * 2005-09-30 2009-06-16 Bristol-Myers Squibb Company Met kinase inhibitors
WO2008102932A1 (en) * 2007-02-21 2008-08-28 Biobud Co., Ltd. Compositions for treating hyperproliferative vascular disorders and cancers
US20100286041A1 (en) * 2007-03-22 2010-11-11 Smithkline Beecham Corporation (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
EP2173342A2 (en) 2007-06-22 2010-04-14 ETH Zurich Antivirals
TWI504395B (zh) 2009-03-10 2015-10-21 Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier
TWI475020B (zh) 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
TWI461197B (zh) * 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
ES2537628T3 (es) 2010-08-27 2015-06-10 Grünenthal GmbH 2-Oxiquinolin-3-carboxamidas sustituidas como moduladores de KCNQ2/3
EP2609084A1 (en) 2010-08-27 2013-07-03 Grünenthal GmbH Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
TWI552750B (zh) 2010-08-27 2016-10-11 歌林達股份有限公司 作為kcnq2/3鉀離子通道調節劑之經取代之2-氧基-及2-硫基-二氫喹啉-3-羧醯胺
BR112013005056A2 (pt) 2010-09-01 2016-05-31 Gruenenthal Gmbh 1-oxo-di-hidroisoquinolina-3-carboxamidas substituídas como moduladores kcnq2/3
US12012394B2 (en) 2018-02-19 2024-06-18 Washington University Alpha-synuclein ligands

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3210063A1 (de) * 1982-03-19 1983-09-22 Hoechst Ag, 6230 Frankfurt Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
US5908930A (en) * 1995-03-15 1999-06-01 Pfizer Inc. 5,10-dihydropyrimdo 4,5-b!quinolin-4(1H)-one tyrosine kinase inhibitors
US6342514B1 (en) * 1996-10-23 2002-01-29 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US6225329B1 (en) * 1998-03-12 2001-05-01 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPases)
EP1147094A1 (en) * 1999-01-15 2001-10-24 Novo Nordisk A/S Non-peptide glp-1 agonists
JP2000309585A (ja) * 1999-02-26 2000-11-07 Kyorin Pharmaceut Co Ltd 6−置換ヘテロキノリンカルボン酸誘導体とその付加塩及びそれらの製造方法
GB0109103D0 (en) * 2001-04-11 2001-05-30 Pfizer Ltd Novel compounds

Similar Documents

Publication Publication Date Title
JP2004526756A5 (US06780888-20040824-C00057.png)
RU2335493C2 (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
RU2395500C2 (ru) 2,4-пиримидиндиамины, применяемые в лечении неопластических болезней, воспалительных и иммунных расстройств
JP2005536475A5 (US06780888-20040824-C00057.png)
JP2017523225A5 (US06780888-20040824-C00057.png)
JP2020507589A5 (US06780888-20040824-C00057.png)
BRPI0306214B1 (pt) 4-oxoquinoline compound and use of this as a hiv integrase inhibitor
JP2003532731A5 (US06780888-20040824-C00057.png)
JP2005526011A5 (US06780888-20040824-C00057.png)
JP2005511547A5 (US06780888-20040824-C00057.png)
ATE448194T1 (de) Verwendung einer pharmazeutischen zusammensetzung mit einem para-aminophenylessigsäurederivat für die behandlung von entzündlichen erkrankungen des magen-darmtrakts
JP2007507494A5 (US06780888-20040824-C00057.png)
RU2006102127A (ru) Производные хинолина и их применение в терапии
JP2008533063A5 (US06780888-20040824-C00057.png)
JP2018507899A5 (US06780888-20040824-C00057.png)
JP2008519783A5 (US06780888-20040824-C00057.png)
JP2005511602A5 (US06780888-20040824-C00057.png)
JP2012508251A5 (US06780888-20040824-C00057.png)
RU2004139050A (ru) Производные 1-сульфонил-4-аминоалкоксииндола в качестве модуляторов 5-нт6 рецептора для лечения заболеваний цнс
JP2004525183A5 (US06780888-20040824-C00057.png)
JP2005502636A5 (US06780888-20040824-C00057.png)
JP2004525178A5 (US06780888-20040824-C00057.png)
JP2021503451A5 (US06780888-20040824-C00057.png)
RU2001126547A (ru) Производные дифенила
JP2004522781A5 (US06780888-20040824-C00057.png)